iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy. (2023 · WIREs Mechanisms of Disease · 被引 10)
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study (2026 · Expert Opinion on Biological Therapy · 被引 1)
Full- versus Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study (2026 · Seminars in Thrombosis and Hemostasis)
Dual REmission in moderate-to-severe AsthMa and Nasal Polyps: a multicentric observational Phase IV real-life study (DREAM-NP) (2026 · Expert Opinion on Biological Therapy)